URL details: ELREXFIOhcp.com
URL title:
ELREXFIO
URL paragraphs:
This site is intended for U.S. healthcare professionals. Menu Close In the single-arm, Phase 2 MagnetisMM-3 study, 57.7% ORR (56/97) and 51.5% ≥VGPR (50/97) were achieved in adult patients with RRMM who had no prior BCMA-directed therapy and had received
URL last crawled:
2024-07-22
URL speed:
0.187 MB/s,
downloaded in 0.500 seconds
We found no external links pointing to this url.